Rising Cancer Burden: Lancet Study

India's Rising Cancer Burden: An Unchecked Crisis

By 2050, cancer deaths worldwide are expected to surge by 74.5%, reaching 18.6 million annually, according to The Lancet's 'Global Burden of Diseases' study. Low- and middle-income countries (LMICs), including India, are poised to bear the brunt of this alarming escalation. India has already witnessed a 26.4% increase in cancer incidence over the last three decades, with rates climbing from 84.8 cases per 100,000 in 1990 to 107.2 cases in 2023. The question is plain but pressing: is India prepared to confront this looming public health catastrophe?

The situation on the ground paints a worrying picture. Cancer remains responsible for 86.9 deaths per 100,000 people in India—a significant rise from 71.7 in 1990. Despite advances in treatment and diagnostics globally, India holds a dismal rank of 168th out of 204 nations in cancer death rates. With healthcare infrastructure already stretched thin and risk factors like tobacco use, poor diets, and widespread consumption of betel nut deeply embedded in societal habits, the systemic response so far appears inadequate.

Institutional Responses: Policy Framework and Gaps

The primary national initiative addressing cancer in India is the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS). It aims to strengthen screening for oral, cervical, and breast cancers and expand treatment access through district-level day-care cancer centres. Complementing this effort is the National Cancer Registry Programme (NCRP), which collects epidemiological data to guide policy interventions.

Recent budgetary allocations for healthcare under the Union Budget 2025-26, totalling ₹99,858 crore, include earmarked funding for cancer care infrastructure and research. Additionally, initiatives such as the Cancer AI & Technology Challenge (CATCH) aim to leverage artificial intelligence for timely diagnoses. Yet, while these policies and programmes may seem robust on paper, the gaps emerge starkly once implementation is scrutinised.

Most government schemes remain focused on urban pockets, leaving vast rural areas largely untouched. Screening infrastructure for cancers like breast and cervical—critical for early detection—remains limited in Tier-II and Tier-III cities. Moreover, India’s per capita health expenditure of just $73 is grossly inadequate compared to countries like Japan, where preventive healthcare investments have reduced cancer mortality rates substantially.

Policy Depth vs Ground Realities

India's cancer burden aligns closely with its demographic and socioeconomic complexities. Certain cancers—oral cavity, oesophageal, and stomach—are uniquely prevalent due to culturally specific risk factors such as betel nut chewing, the consumption of hot beverages, and diets rich in pickled and preserved foods. Yet, public health communication campaigns addressing these modifiable risks remain sporadic, fragmented, and poorly funded.

Preventive healthcare still fails to attract political and administrative urgency. Take tobacco use: while India has ratified the WHO Framework Convention on Tobacco Control, its tobacco taxation policies fail to adequately deter consumption. Smokeless tobacco—a leading cause of oral cancer—remains inexpensively and widely available. Enforcement of measures such as pictorial warnings also lacks consistency, particularly in rural areas.

Additionally, India's cancer death rate of 86.9 per 100,000 reflects its systemic inability to ensure early detection. Merely focusing on enhancing treatment infrastructure is akin to applying a band-aid; the root lies in strengthening primary healthcare systems and rolling out nationwide screening programmes similar to South Korea’s, where citizens above the age of 40 receive free biannual cancer screening.

Structural Tensions and Inter-Institutional Coordination

The divergence between policy intent and execution becomes even starker when analysing inter-agency coordination. Cancer care in India spans multiple stakeholders: the Health Ministry, state governments, district hospitals, and even private service providers. However, fragmented accountability mechanisms between these actors weaken efficiency.

Centre-state friction further complicates matters. Health is a state subject, and disparities in state-level governance result in uneven progress. Kerala, for instance, has outpaced others in implementing cancer-screening drives due to its prioritisation of healthcare funding, while states like Bihar lag significantly in infrastructure and awareness campaigns.

Budgetary allocations, though substantial in aggregate, also unmask structural inequities. While ₹99,858 crore for healthcare may seem impressive, the proportion allocated explicitly to non-communicable diseases, including cancer, is unclear. The lack of targeted fund disbursal—combined with cumbersome bureaucratic processes—delays ground-level impact.

A Global Case Study: Lessons from Japan

Japan offers a significant contrast with its proactive war on cancer. With a cancer mortality rate of 77 per 100,000—far below India’s—Japan's success lies in its emphasis on a preventive approach. Universal health insurance ensures all citizens can access regular check-ups, while dedicated legislation like the Cancer Control Act mandates a systematic national strategy. Moreover, investments in public awareness campaigns discourage behavioural risks like tobacco and excessive alcohol consumption.

India’s fragmented approach falls short of this model, especially when it comes to prioritising preventive measures. Scaling up universally accessible cancer screening and providing financial protection to patients via health insurance are pathways India must consider adopting more aggressively.

Looking Ahead: What Would Success Actually Look Like?

Success for India hinges on four pillars: robust preventive healthcare, equitable resource distribution, widespread awareness campaigns, and strong enforcement of regulatory frameworks targeting risk factors like tobacco. Metrics to track progress must include a decline in stage-III and stage-IV cancer diagnoses, reduced tobacco consumption rates, and the establishment of cancer treatment facilities in rural districts.

However, the road to these outcomes is paved with challenges. Beyond financial constraints, addressing societal norms (such as betel nut use) and streamlining an unwieldy health bureaucracy require long-term commitment and political will. The incorporation of emerging technologies, such as AI diagnostics and CAR-T cell therapy, could further revolutionise outcomes—but only if accompanied by equitable access for low-income groups.

Practice Questions for UPSC

Prelims Practice Questions

Frequently Asked Questions